Intrexon | XON - DEBITO





DEBITO Cambiamento Data
Agenus USD 35.54M 2.34M 2025-03
Alaunos Therapeutics USD 10.99M 5.78M 2023-03
Amgen USD 54.6B 17M 2025-12
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 312.77M 53.52M 2025-12
AstraZeneca USD 33.92B 4.3B 2026-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Heron Therapeutics USD 149.65M 157K 2024-09
Incyte USD 39.43M 982K 2026-03
Intrexon USD 0 13.82M 2024-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Ligand Pharmaceuticals USD 451.49M 494K 2025-12
MacroGenics USD 36.51M 500K 2026-03
MannKind USD 367.44M 247.53M 2025-12
Merck USD 49.34B 7.97B 2025-12
Novartis USD 47B 11.62B 2026-03
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Veracyte USD 39.65M 799K 2025-12
Xencor USD 187.75M 118.48M 2025-12